REALCAN PHARMACEUTICAL GROUP CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.55 CNY | +6.25% |
|
-10.84% | -22.02% |
| Sales 2021 | 21.06B 2.91B | Sales 2022 | 12.31B 1.7B | Capitalization | 6.17B 852M |
|---|---|---|---|---|---|
| Net income 2021 | 131M 18.1M | Net income 2022 | -1.83B -253M | EV / Sales 2021 | 0.28 x |
| Net cash position 2021 | 34.82M 4.81M | Net cash position 2022 | 1.34B 185M | EV / Sales 2022 | 0.39 x |
| P/E ratio 2021 |
43.7
x | P/E ratio 2022 |
-3.32
x | Employees | 5,118 |
| Yield 2021 |
0.23% | Yield 2022 |
-
| Free-Float | 60.54% |
More Fundamentals
* Assessed data
More news
| 1 day | +6.25% | ||
| 1 week | -10.84% | ||
| Current month | -15.84% | ||
| 1 month | -7.61% | ||
| 3 months | -14.72% | ||
| 6 months | -27.35% | ||
| Current year | -22.02% |
1 week
2.39
2.95
1 month
2.393.17
Current year
2.053.34
1 year
2.053.96
3 years
2.056.73
5 years
2.059.27
10 years
2.0524.15
| Managers | Title | Age | Since |
|---|---|---|---|
Ren Hua Zhang
FOU | Founder | 58 | 09-11-20 |
Yun Feng
DFI | Director of Finance/CFO | 54 | 21-04-25 |
Xu Han
CHM | Chairman | 59 | 09-11-20 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ren Hua Zhang
FOU | Founder | 58 | 09-11-20 |
Xu Han
CHM | Chairman | 59 | 09-11-20 |
Bo Yang
BRD | Director/Board Member | 41 | 09-11-20 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-17 | 2.55 | +6.25% | 25,173,800 |
| 24-04-16 | 2.4 | -8.75% | 32,896,700 |
| 24-04-15 | 2.63 | -8.36% | 46,622,200 |
| 24-04-12 | 2.87 | -1.03% | 20,372,700 |
| 24-04-11 | 2.9 | +1.40% | 22,005,500 |
End-of-day quote Shenzhen S.E., April 16, 2024
More quotes
Realcan Pharmaceutical Group Co., Ltd., formerly REALCAN PHARMACEUTICAL CO., LTD., is a China-based medical service provider. The Company operates its businesses through three segments. The Medical segment is engaged in the provision of Chinese medicine materials, Chinese medicine tablets, Chinese patent medicines, chemical drug materials, chemical preparations, antibiotics, biochemical pharmaceuticals, biological products, psychotropic substances, anesthetic medicines and peptide hormones. The Equipment is engaged in the provision of medical equipment. The Mobile Medical segment is engaged in the provision of medical and logistics services and mobile medical information services. The Company conducts its businesses mainly within domestic markets, with Shandong as its main market.
Sector
Pharmaceuticals
Calendar
2024-04-29
- Q1 2024 Earnings Release
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -22.02% | 530M | |
| +13.59% | 69.11B | |
| +5.67% | 25.91B | |
| +5.02% | 8.01B | |
| -3.28% | 7.91B | |
| -27.52% | 7.27B | |
| -0.06% | 4.51B | |
| +21.54% | 4.48B | |
| -2.45% | 3.95B | |
| -4.26% | 3.79B |
- Stock Market
- Equities
- 002589 Stock
